Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to...

Pivotal Study of Norvir Tablet Bioavailability Will Form the Basis of Request for Priority Regulatory Review MEXICO CITY, August 7, 2008 /PRNewswire-FirstCall/ -- Abbott presented pivotal data at the XVII International AIDS Conference (AIDS 2008) in Mexico City today showing that its investigational Norvir(R) (ritonavir) tablet and the current soft-gelatin capsule provide similar levels of drug in the blood. The heat-stable Norvir tablet will not require refrigeration, making it more convenient for patients to use, particularly in developing countries where the majority of people with HIV live. "The heat-stable formulation of ritonavir may help to further expand protease inhibitor-based HAART (highly active antiretroviral therapy) in regions where the need for refrigeration of HIV medicines is a major barrier to treatment and... [read full story]